Evidence map›Paper›PMID 39081744›Full record

ArticleKidney international reports2024

Myeloperoxidase-Associated Membranous Nephropathy in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.

Kenta Tominaga, Etsuko Toda, Kazuhiro Takeuchi, Shoichiro Takakuma, Emi Sakamoto, Hideaki Kuno, Yusuke Kajimoto, Yasuhiro Terasaki, Shinobu Kunugi, Mika Terasaki and 4 more

Abstract read
In one paragraph

Article in Kidney international reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kenta TominagaDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Etsuko TodaDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Kazuhiro TakeuchiDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Shoichiro TakakumaDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Emi SakamotoDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Hideaki KunoDivision of Nephrology and Hypertension, The Jikei University School of Medicine, Tokyo, Japan.
Yusuke KajimotoDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Yasuhiro TerasakiDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Shinobu KunugiDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Mika TerasakiDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Hiroyasu GotoDepartment of Nephrology and Endocrinology, National Defense Medical College, Saitama, Japan.
Toshihiko ImakiireDepartment of Nephrology and Endocrinology, National Defense Medical College, Saitama, Japan.
Naoki OshimaDepartment of Nephrology and Endocrinology, National Defense Medical College, Saitama, Japan.
Akira ShimizuDepartment of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN) is characterized by pauci-immune crescentic GN. Myeloperoxidase ANCA-associated GN (MPO-ANCA GN) with membranous nephropathy (MN), where bright granular capillary MPO and IgG staining along the glomerular basement membrane (GBM) is present, has been reported; however, its clinicopathological features remain unclear. Methods: We investigated 7 MPO-ANCA GN with MN and 11 control cases (6 MPO-ANCA GN and 5 primary MN cases). Proteomics of laser microdissected glomeruli followed by immunohistochemical analysis was performed to identify causal antigens in MPO-ANCA GN with MN. We described the clinicopathological features of MPO-associated MN compared with those of MPO-ANCA GN and primary MN. Results: We detected proteomic MPO and granular capillary MPO deposits in all MPO-ANCA GN with MN cases. Confocal microscopy revealed MPO and IgG colocalization along the GBM. MPO-associated MN clinicopathological features include greater proteinuria, a higher fibrous crescent rate, and a lower MPO-ANCA titer than MPO-ANCA GN. The estimated glomerular filtration rate (eGFR) and urinary protein excretion were lower in MPO-associated MN than in primary MN. Conclusion: MPO-associated MN, a unique type of secondary MN where MPO serves as the causal antigen, is a subset of MPO-ANCA GN with MN. Prolonged periods of MPO-ANCA GN and a low MPO-ANCA titer might be related to MPO-associated MN development.

Indexed as

antigenantineutrophil cytoplasmic antibodyglomerular basement membraneglomerulonephritismembranous nephropathymyeloperoxidase

Identifiers

PMID39081744
PMCPMC11284429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.